Optimising the chick chorioallantoic membrane xenograft model of neuroblastoma for drug delivery

CDK4/6 Inhibition Controls Proliferation of Bladder Cancer and Transcription of RB1

(2016) Anuja Sathe et al.   JOURNAL OF UROLOGY

Quantification of cancer cell extravasation in vivo

(2016) Yohan Kim et al.   Nature Protocols

New horizons in tumor microenvironment biology: challenges and opportunities

(2015) Fei Chen et al.   BMC Medicine

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

(2015) Mateusz Rytelewski et al.   Jove-Journal of Visualized Experiments

Cellular memory of hypoxia elicits neuroblastoma metastasis and enables invasion by non-aggressive neighbouring cells

(2015) A Herrmann et al.   Oncogenesis

MYCN gene expression is required for the onset of the differentiation programme in neuroblastoma cells

(2014) L Guglielmi et al.   Cell Death & Disease

Small Molecule Inhibitors of Aurora-A Induce Proteasomal Degradation of N-Myc in Childhood Neuroblastoma

(2013) Markus Brockmann et al.   CANCER CELL

Identification and characterisation of STMN4 and ROBO2 gene involvement in neuroblastoma cell differentiation

(2012) Pei-Ju Sung et al.   CANCER LETTERS

Tyrosine phosphatase inhibitors combined with retinoic acid can enhance differentiation of neuroblastoma cells and trigger ERK- and AKT-dependent, p53-independent senescence

(2012) Owen Clark et al.   CANCER LETTERS

Adaptive Dosing Approaches to the Individualization of 13-Cis-Retinoic Acid (Isotretinoin) Treatment for Children with High-Risk Neuroblastoma

(2012) G. J. Veal et al.   CLINICAL CANCER RESEARCH

Chick Chorioallantoic Membrane (CAM) Assay as an In Vivo Model to Study the Effect of Newly Identified Molecules on Ovarian Cancer Invasion and Metastasis

(2012) Noor A. Lokman et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Exploitation of chick embryo environments to reprogram MYCN-amplified neuroblastoma cells to a benign phenotype, lacking detectable MYCN expression

(2012) R Carter et al.   Oncogenesis

The FRA2C common fragile site maps to the borders of MYCN amplicons in neuroblastoma and is associated with gross chromosomal rearrangements in different cancers

(2011) Anne Blumrich et al.   HUMAN MOLECULAR GENETICS

Neuroblastoma: Therapeutic strategies for a clinical enigma

(2010) Shakeel Modak et al.   CANCER TREATMENT REVIEWS

Stabilization of N-Myc Is a Critical Function of Aurora A in Human Neuroblastoma

(2009) Tobias Otto et al.   CANCER CELL

Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

(2009) Katherine K. Matthay et al.   JOURNAL OF CLINICAL ONCOLOGY

The chick embryo chorioallantoic membrane as a model to study tumor metastasis

(2008) Anca Maria Cimpean et al.   ANGIOGENESIS

The International Neuroblastoma Risk Group (INRG) Staging System: An INRG Task Force Report

(2008) Tom Monclair et al.   JOURNAL OF CLINICAL ONCOLOGY